These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11121543)

  • 1. Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology.
    Gómara MJ; Ercilla G; Alsina MA; Haro I
    J Immunol Methods; 2000 Dec; 246(1-2):13-24. PubMed ID: 11121543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection.
    Gómara MJ; Riedemann S; Vega I; Ibarra H; Ercilla G; Haro I
    J Immunol Methods; 2000 Feb; 234(1-2):23-34. PubMed ID: 10669766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Features of antigen-antibody interaction during use of linear synthetic peptides and multipeptide antigen modeling antigenic determinants of hepatitis A virus].
    Kruglov IV; Simonova TV; Perez JA; Haro I
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):31-4. PubMed ID: 19459474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatitis A virus antibody response elicited in mice by different forms of a synthetic VP1 peptide.
    Haro I; Pinto RM; Gonzalez-Dankaart JF; Perez JA; Reig F; Bosch A
    Microbiol Immunol; 1995; 39(7):485-90. PubMed ID: 8569533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational behavior of the HAV-VP3(110-121) peptidic sequence and synthetic analogs in membrane environments studied by CD and computational methods.
    Pérez JA; Cantó J; Reig F; Pérez JJ; Haro I
    Biopolymers; 1998 Jun; 45(7):479-92. PubMed ID: 9577229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the immunogenicity of a synthetic peptide bearing a VP3 epitope of hepatitis A virus.
    Pintó RM; González-Dankaart JF; Sánchez G; Guix S; Gómara MJ; García M; Haro I; Bosch A
    FEBS Lett; 1998 Oct; 438(1-2):106-10. PubMed ID: 9821968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid-model membrane interactions with branched polypeptide conjugates of a hepatitis A virus peptide epitope.
    Nagy IB; Alsina MA; Haro I; Reig F; Hudecz F
    Bioconjug Chem; 2000; 11(1):30-8. PubMed ID: 10639082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic peptides for the immunodiagnosis of hepatitis A virus infection.
    Gauna A; Losada S; Lorenzo M; Bermúdez H; Toledo M; Pérez H; Chacón E; Noya O
    J Immunol Methods; 2015 Dec; 427():1-5. PubMed ID: 26321053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chain length of HAV-VP3 synthetic peptides on its interaction with biomembrane models.
    Sospedra P; Muñoz M; García M; Alsina MA; Mestres C; Haro I
    Biopolymers; 2000 Dec; 54(7):477-88. PubMed ID: 10984400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope analysis using kinetic measurements of antibody binding to synthetic peptides presenting single amino acid substitutions.
    Zeder-Lutz G; Altschuh D; Denery-Papini S; Briand JP; Tribbick G; Van Regenmortel MH
    J Mol Recognit; 1993 Jun; 6(2):71-9. PubMed ID: 7508237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
    de Prat-Gay G
    Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic evidence that monoclonal antibodies recognize the dominant conformation of medium-sized synthetic peptides.
    Lang E; Szendrei GI; Lee VM; Otvos L
    J Immunol Methods; 1994 Mar; 170(1):103-15. PubMed ID: 7512605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new continuous epitope of hepatitis A virus.
    Bosch A; González-Dankaart JF; Haro I; Gajardo R; Pérez JA; Pintó RM
    J Med Virol; 1998 Feb; 54(2):95-102. PubMed ID: 9496366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes between human immunodeficiency virus type 1 nucleocapsid protein NCp7 and its precursor NCp15 as detected by anti-NCp7 monoclonal antibodies.
    Tanchou V; Delaunay T; Bodéus M; Roques B; Darlix JL; Benarous R
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2457-66. PubMed ID: 7595349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design.
    Haro I; Pérez S; García M; Chan WC; Ercilla G
    FEBS Lett; 2003 Apr; 540(1-3):133-40. PubMed ID: 12681496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Antibodies against Hepatitis A Virus (HAV) by a Surface Plasmon Resonance (SPR) Biosensor: A New Diagnosis Tool Based on the Major HAV Capsid Protein VP1 (SPR-HAVP1).
    Santos GMCD; Alves CR; Pinto MA; Amado Leon LA; Souza-Silva F
    Sensors (Basel); 2021 May; 21(9):. PubMed ID: 34063564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
    Huisman JG; Carotenuto A; Labrijn AF; Papavoine CH; Laman JD; Schellekens MM; Koppelman MH; Hilbers CW
    Biochemistry; 2000 Sep; 39(35):10866-76. PubMed ID: 10978173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-based recombinant diagnostic antigen to distinguish natural infection from vaccination with hepatitis A virus vaccines.
    Su Q; Guo M; Jia Z; Qiu F; Lu X; Gao Y; Meng Q; Tian R; Bi S; Yi Y
    J Virol Methods; 2016 Jul; 233():41-5. PubMed ID: 26994964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus.
    Stewart DR; Morris TS; Purcell RH; Emerson SU
    J Infect Dis; 1997 Sep; 176(3):593-601. PubMed ID: 9291304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.